culture-related diagnostic issues in, 609
development and course of, 608–609
diagnostic criteria for, 602–606
diagnostic features of, 607–608
diagnostic markers for, 609–610
differential diagnosis of, 610
functional consequences of, 610
gender-related diagnostic issues in, 609
prevalence of, 608
risk and prognostic factors for, 609
specifiers for, 606–607
subtypes of, 591, 603–604,  606, 611–643major or mild frontotemporal neuro-
cognitive disorder, 591, 603, 614–618
major or mild neurocognitive disorder 
due to Alzheimer’s disease, 591, 603, 
611–614
major or mild neurocognitive disorder 
due to another medical condition, 
591, 604, 641–642
major or mild neurocognitive disorder 
due to HIV infection, 591, 604, 632–
634
major or mild neurocognitive disorder 
due to Huntington’s disease, 591, 
604, 638–641
major or mild neurocognitive disorder 
with Lewy bodies, 591, 603, 618–621
major or mild neurocognitive disorder 
due to multiple etiologies, 591, 604, 
642–643
major or mild neurocognitive disorder 
due to Parkinson’s disease, 591, 604, 
636–638
major or mild neurocognitive disorder 
due to prion disease, 591, 604,  634–
636
major or mild neurocognitive disorder 
due to traumatic brain injury, 591, 
603, 624–627, 626
major or mild substance/medication-